A股股票代码：601336 A股股票简称：新华保险 编号：2025-013号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 第八届董事会第三十一次会议决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2025 年 3 月 13 日以电 子邮件方式向全体董事发出第八届董事会第三十一次会议（以下简称"会议"） 通知和材料，会议于 2025 年 3 月 27 日在北京市以现场方式召开。会议应到董事 10 人，现场出席董事 10 人，公司监事和高级管理人员列席了会议。会议的召集、 召开符合《中华人民共和国公司法》《新华人寿保险股份有限公司章程》和《新 华人寿保险股份有限公司董事会议事规则》的有关规定，所作的决议合法、有效。 会议由公司董事长杨玉成主持，经与会董事审议和现场表决，形成如下会议 决议： 一、审议通过了《关于分红业务 2024 年度红利分配方案的议案》。 表决情况：同意 10 票，反对 0 票，弃权 0 票。 二、审议 ...

Financial Performance - The company achieved a total operating revenue of CNY 170.51 billion in 2024, representing a year-on-year growth of 2.8%[26]. - The net profit attributable to shareholders was CNY 26.23 billion, marking a remarkable growth of 201.1% year-on-year, reaching a historical high[26]. - The company achieved original insurance premium income of 170.5 billion yuan in 2024, with total assets reaching 1.69 trillion yuan, indicating stable overall operations[41]. - The company reported a total investment income of 16,306 million RMB, a substantial recovery from a loss of 3,775 million RMB in 2023[71]. - The total investment return rate improved to 5.8%, up by 4.0 percentage points from 1.8% in 2023[114]. - The company’s basic earnings per share rose to 8.41 RMB, marking a 201.4% increase from 2.79 RMB in 2023[61]. - The company’s total equity attributable to shareholders decreased by 8.4% to 96,240 million RMB, primarily due to increased losses recognized in other comprehensive income[60]. - The company’s operating revenue for 2024 reached 132,555 million RMB, an increase of 85.3% compared to 71,547 million RMB in 2023[59]. - Net profit attributable to shareholders of the parent company surged to 26,229 million RMB, reflecting a 201.1% increase from 8,712 million RMB in the previous year[59]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1.99 per share for the year-end, totaling CNY 62.08 billion, which, along with the mid-year dividend of CNY 0.54 per share, brings the total cash dividends for 2024 to CNY 78.93 billion, accounting for approximately 30.1% of the net profit attributable to shareholders[5]. - The company plans to distribute a total cash dividend of CNY 78.93 billion for 2024, an increase of 197.6% compared to the previous year[25]. - The company plans to distribute a total dividend of CNY 7.893 billion for the year, accounting for 30.1% of net profit attributable to shareholders[53]. Risk Management - The company has identified several risks, including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, and has implemented measures to manage and control these risks effectively[5]. - The company anticipates facing risks due to complex international environments and ongoing industry adjustments, necessitating continuous risk monitoring[148]. - The company will optimize its comprehensive risk management system to ensure effective operation and compliance with regulatory standards[148]. Corporate Governance - The financial report for 2024 has been audited by Deloitte Huayong, which issued a standard unqualified audit opinion[5]. - The company’s chairman and senior management have guaranteed the accuracy and completeness of the financial report[5]. - The company has no violations of decision-making procedures regarding external guarantees[5]. - The company has no instances of more than half of the directors being unable to ensure the authenticity of the report[5]. - The company is actively working on compliance with regulatory requirements regarding board member qualifications and appointments[187]. Product and Service Development - The company launched multiple service brands, including "新华尊" and "新华安," to enhance customer experience across various sectors[29][30]. - The company launched 58 new insurance products in 2024, enhancing its offerings in health, retirement, accident, medical, and wealth management insurance[92]. - The company has established a digital service chain that includes features like "digital human" product explanations and intelligent product recommendations, enhancing customer experience[37]. - The company has developed a collaborative model of "insurance + service + investment," managing nearly 2 trillion yuan in assets through its asset management platform[42]. Investment and Asset Management - The total investment assets increased to CNY 1,629.36 billion, up from CNY 1,345.48 billion in 2023, reflecting a strong growth in investment capabilities[18]. - The investment return rate for 2024 was reported at 5.8%, with a comprehensive investment return rate of 8.5%[28]. - The company plans to leverage its long-term capital advantages to support the real economy and enhance investment returns through strategic asset allocation[105]. - The company has established a service framework to support national strategies, with an investment scale of CNY 1,088.8 billion in the real economy[24]. Human Resources and Talent Development - The company launched the "XIN Generation" talent development project in 2024, resulting in a significant increase in the number of IDA members by over 100% year-on-year[33]. - The company’s board of directors has undergone several changes, including the appointment of new assistant presidents Liu Chen and Liu Zhiyong in early 2024[190]. Compliance and Regulatory Matters - The company does not face any non-operational fund occupation by controlling shareholders or related parties[5]. - The company has no violations of decision-making procedures regarding external guarantees[5]. - The company is in the process of finalizing the annual performance bonuses for employee representatives and senior management for 2024[190]. Market Position and Recognition - The company has been recognized as one of the top 50 most valuable insurance brands globally for 10 consecutive years and has received an "A2" financial strength rating from Moody's in 2024[39][45]. - The company emphasizes the importance of high-quality development in the insurance industry, aligning with national policies for sustainable growth[145].

重要内容提示： 每股派发现金红利人民币 1.99 元（含税）。 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体 日期将在权益分派实施公告中明确。 本次利润分配方案尚待公司 2024 年年度股东大会审议通过后方可实 施。 A股股票代码：601336 A股股票简称：新华保险 编号：2025-015号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 2024年年度利润分配方案公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任何 虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 本次利润分配方案不触及《上海证券交易所股票上市规则（2024 年 4 月修订）》（以下简称《股票上市规则》）第 9.8.1 条第一款第（八）项规定的可能 被实施其他风险警示的情形。 一、利润分配方案内容 （一）利润分配方案的具体内容 经德勤华永会计师事务所（特殊普通合伙）审计，新华人寿保险股份有限公 司（以下简称"公司"）2024年度母公司财务报表净利润为252.02亿元（人民币， 下同），合并财务报表归属于母公司股东的净利润为262.29亿元。 ...

智通财经APP讯，新华保险(01336)公布2024年业绩，公司寿险业务结构和业务品质持续优化，规模和价 值实现全面增长。全年实现原保险保费收入1,705.11亿元，同比增长2.8%;收入合计1320.44亿元，同比 增长82.7%。一年新业务价值62.53亿元，同比增长106.8%;首年保费口径下新业务价值率14.6%，较2023 年的 6.7%提高7.9个百分点;实现归属于母公司股东的净利润262.29亿元，较上年增长201.1%，达到历史 新高。末期现金股利每股1.99元(含税)。 公告称，净利增长主要受资本市场上涨的影响，2024年投资业绩同比增长。2024年，公司投资组合综合 投资收益率为8.5%，总投资收益率为5.8%，净投资收益率为3.2%。 2024年，公司业务结构持续优化。长期险首年期交保费占长期险首年保费比例为70.1%，较上年同期提 升 12.6个百分点;十年期及以上期交保费占长期险首年期交保费比例为12.6%，较上年同期有所提升;续 期保费占总保费的比例为75.0%，"压舱石"作用稳固。传统险和分红险长期险首年保费占长期险首年保 费比例合计96.5%，占比保持稳定。 2024年，公司深 ...

Dividends and Profit Distribution - New China Life Insurance Company announced a total cash dividend of RMB 7.893 billion for 2024, accounting for 30.1% of the net profit attributable to shareholders[7]. - The company plans to distribute a final cash dividend of RMB 1.99 per share, totaling RMB 6.208 billion, pending shareholder approval[7]. - The interim cash dividend distributed in 2024 was RMB 0.54 per share, amounting to RMB 1.685 billion[7]. - The company plans to distribute a cash dividend of 1.99 yuan per share for the year-end, totaling 62.08 billion, which is an increase of 197.6% compared to the previous year[30]. Financial Performance - The total revenue for 2024 reached 170,511 million, an increase from 165,903 million in 2023[23]. - The net profit attributable to shareholders reached CNY 26.229 billion, a significant increase of 201.1%, marking a historical high[31]. - The total assets grew by 20.6% to 1,692,297 million from 1,403,257 million in 2023[68]. - The pre-tax profit surged to 28,141 million, reflecting a 410.3% increase from 5,515 million in 2023[66]. - Operating cash flow increased by 5.2% to 96,290 million, compared to 91,548 million in 2023[66]. Risk Management - The company faces various risks including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, which are being effectively managed[7]. - The company acknowledges potential risks from a complex international environment and changing demographic and customer needs, requiring ongoing risk management attention[134]. - To address risks, the company will optimize its comprehensive risk management system and strengthen risk management mechanisms and execution[135]. Investment and Asset Management - The company's investment scale reached CNY 1,629.36 billion, with a total investment return rate of 5.8% and a comprehensive investment return rate of 8.5%[32]. - The company has supported real economy investments totaling 1,088.8 billion, with approximately 483.3 billion allocated to national strategic investments[29]. - The company plans to continue focusing on long-term value and strategic investments to support the real economy[108]. - The company's total investment assets reached 1,629,361 million, a 21.1% increase from 1,345,475 million in 2023[111]. Product Development and Innovation - The company launched 58 new insurance products in 2024, covering various areas including health, retirement, and wealth management[99]. - The company is investing in R&D for new technologies, allocating $D million towards innovation initiatives aimed at enhancing product offerings[5]. - The company is focusing on a customer-centric strategy and has developed a multi-dimensional product supply system to meet diverse insurance needs[60]. Management and Governance - The company has appointed Mr. Pan Xing as the Chief Actuary, pending regulatory approval[6]. - The company has a diverse board with members holding various significant positions in other financial institutions, enhancing its governance and strategic direction[179][180][181][182]. - The total pre-tax remuneration for the company's directors, supervisors, and senior management during the reporting period amounted to CNY 16.814 million[200]. Customer Engagement and Satisfaction - Customer satisfaction metrics have improved, with a G% increase in positive feedback from users regarding recent product updates[8]. - The retention rate for individual life insurance business improved, with a 13-month retention rate of 95.7%, up 5.9 percentage points year-on-year[84]. Future Outlook - The company emphasizes that forward-looking statements regarding future plans and strategies do not constitute a commitment to investors[7]. - The insurance industry in China is expected to benefit from a long-term positive economic trend, with a focus on high-quality development and risk prevention as outlined in the "New National Ten Measures"[131]. - By 2025, the company plans to implement a "steady progress" approach, emphasizing customer-centric reforms and improving resource allocation efficiency[133].

Core Viewpoint - The company, Xinhua Insurance, is actively promoting the entry of long-term capital into the market, positioning itself as a "patient capital" representative to support the stable development of the capital market [1][2][3]. Group 1: Long-term Capital Entry - Xinhua Insurance manages over 1 trillion yuan in commercial insurance funds and enterprise pension funds, recognizing the importance of facilitating the entry of long-term capital into the market [1]. - In January 2025, Xinhua Insurance announced its acquisition of shares in Hangzhou Bank, demonstrating its commitment to being a leader in long-term capital investment [2]. - The company has also invested in China National Pharmaceutical Group and Shanghai Pharmaceuticals, enhancing its presence in the healthcare sector and supporting the stable development of the capital market [2]. Group 2: Long-term Investment Reform - In March 2025, Xinhua Insurance was approved to participate in a long-term investment reform pilot program with a scale of 60 billion yuan, reflecting recognition of its commitment to value investment [3]. - The company has established the Honghu Fund, which has invested 50 billion yuan in key industries, balancing effectiveness, safety, and liquidity [3]. Group 3: Supporting the Real Economy - Xinhua Insurance employs various methods to utilize long-term capital, including the establishment of the Zhijichin Fund to support the integrated circuit industry and investments in green bonds to promote clean energy projects [4]. - The company has invested 300 million yuan in Agricultural Bank's green bonds and 200 million yuan in Beijing Bank's micro-enterprise bonds, addressing financing challenges for small and micro enterprises [4]. Group 4: Financial Performance - Xinhua Insurance expects a net profit of 23.958 billion to 25.7 billion yuan for 2024, representing a year-on-year increase of 175% to 195% [6]. - The company reported a 29% year-on-year increase in original premium income in the first two months of 2025, exceeding 50 billion yuan [6].

A股股票代码：601336 A股股票简称：新华保险 编号：2025-012号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 关于召开2024年度业绩发布会的公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 重要内容提示： 二、业绩发布会召开的时间、地点 （三）网络直播地址：https://s.comein.cn/79gjiqe1 三、本公司出席人员 本公司董事长杨玉成，总裁、首席财务官龚兴峰，副总裁秦泓波，副总裁王 1 会议召开时间：2025 年 3 月 28 日（星期五）15:00-16:30 会议召开方式：网络直播 网络直播地址：https://s.comein.cn/79gjiqe1 投资者可于 2025 年 3 月 24 日（星期一）23:59 前将相关问题通过电子邮 件的形式发送至新华人寿保险股份有限公司（以下简称"本公司"）投资者 关系邮箱：ir@newchinalife.com。 一、业绩发布会类型 本公司拟于 2025 年 3 月 28 日在上海证券交易所 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對本通告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 承董事會命 新華人壽保險股份有限公司 楊玉成 董事長 中國北京，2025 年 3 月 14 日 於本通告日期，本公司董事長、執行董事為楊玉成；執行董事為龔興峰；非執 行董事為何興達、楊雪、胡愛民和李琦強；及獨立非執行董事為馬耀添、賴觀 榮、徐徐和郭永清。 董事會會議通告 新華人壽保險股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈， 本公司將於二零二五年三月二十七日（星期四）舉行董事會會議，藉以(其中包 括)考慮及批准本公司及其附屬公司截至二零二四年十二月三十一日止年度的業 績及其發佈，並考慮派發末期股息，以及處理其他事項。 [公司商標] 新華人壽保險股份有限公司 ...

新华人寿保险股份有限公司 保费收入公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 特此公告。 | A股股票代码：601336 | A股股票简称：新华保险 编号：2025-011号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司董事会 根据中华人民共和国财政部《企业会计准则第 25 号——原保险合同》（财 会〔2006〕3 号）及《保险合同相关会计处理规定》（财会〔2009〕15 号），新华 人寿保险股份有限公司（以下简称"公司"）于 2025 年 1 月 1 日至 2025 年 2 月 28 日期间累计原保险保费收入为人民币 5,112,431 万元，同比增长 29%。公司加 强顶层设计，强化渠道基础管理，绩优人力带动业务增长，改革创新红利逐步释 放。 上述原保险保费收入数据未经审计，提请投资者注意。 2025 年 3 月 12 日 ...

新华人寿保险股份有限公司 2025 年第二次临时股东大会 会议材料 二〇二五年三月十一日 北京 1/4 新华人寿保险股份有限公司 2025 年第二次临时股东大会议程 会议时间 ：2025 年 3 月 31 日（星期一）下午 14 点 30 分 会议地点 ：北京市朝阳区建国门外大街甲 12 号新华保险大厦 21 层 各位股东： 为进一步增强公司资本实力，提升核心偿付能力充足率，优化资本结构， 支持公司业务持续稳健发展，公司拟在境内发行金额不超过人民币 100 亿元（含 100 亿元）的无固定期限资本债券。 在取得股东大会和监管机构批准的前提下，公司计划按照下列各项条款及 条件在境内发行无固定期限资本债券： 会议召集人：新华人寿保险股份有限公司董事会 议程内容 特别决议事项 关于发行境内无固定期限资本债券的议案 2/4 一、宣布会议开始及会议议程 二、审议议案 三、回答股东提问 四、宣布出席会议股东及股东代理人人数、代表股份数 五、现场投票表决 六、休会、统计现场表决结果 七、宣布现场表决结果 议案 关于发行境内无固定期限资本债券的议案 1.发行规模：不超过人民币 100 亿元（含 100 亿元），一次或分期发行 ...